欢迎来到《四川大学学报(医学版)》

高原藏族人群血常规指标与代谢综合征的关联研究

Association Between Blood Routine Index and Metabolic Syndrome in High-altitude Tibetan Population

  • 摘要:
    目的  探讨西藏藏族人群血常规指标与代谢综合征(metabolic syndrome, MetS)患病率及其风险因素的相关性。
    方法  2021年8月–2023年8月,通过多阶段分层整群随机抽样法,对西藏拉萨、阿里、那曲地区藏族人群进行问卷调查、人体测量、实验室检查,研究共纳入2832人。经调整潜在的混杂因素,采用logistic回归分析血常规指标与MetS的相关性。
    结果  MetS患病率为11.5%,男性患病率为12.9%,女性患病率为10.6%。经混杂调整后结果显示,白细胞(WBC)、血红蛋白(Hb)、红细胞压积(HCT)、血小板体积分布宽度(PDW)与MetS患病有关。与最低的三分位数组Q1相比,WBC的Q2、Q3组的比值比(OR)OR值分别为1.629〔95%置信区间(95%CI):1.164~2.279,P=0.004〕和1.621(95%CI:1.14~2.292,P=0.006);Hb的Q2、Q3组的OR值分别为0.523(95%CI:0.325~0.843,P=0.008)和0.435(95%CI:0.212~0.889,P=0.022);HCT的Q2、Q3组的OR值分别为1.818(95%CI:1.123~2.943,P=0.015)和2.480(95%CI:1.208~5.089,P=0.013);PDW的Q2、Q3组的OR值分别为0.562(95%CI:0.358~0.881,P=0.012)和0.614(95%CI:0.381~0.991,P=0.046)。
    结论 西藏藏族MetS患病率低于国内水平,WBC、Hb、HCT、PDW平均水平与MetS患病有关,其中WBC和HCT为MetS患病的危险因素;Hb和PDW为保护因素,建议将血常规作为一种简单、有效的指标纳入代谢性疾病管理和控制。

     

    Abstract:
    Objective To investigate the relationship between blood routine indicators and the prevalence of metabolic syndrome (MetS) and its risk factors in the Tibetan population in Xizang.
    Methods From August 2021 to August 2023, a multi-stage stratified cluster random sampling method was used to conduct a questionnaire survey, anthropometric measurements, and laboratory examinations of the Tibetan population in the Lhasa, Ali, and Naqu areas of Xizang. A total of 2 832 people were included in the study. After adjusting for potential confounding factors, logistic regression analysis was used to examine the correlation between blood routine indicators and MetS.
    Results  The prevalence of MetS was 11.5%, with rates of 12.9% among males and 10.6% among females. After adjusting for confounding factors, white blood cell count (WBC), hemoglobin (Hb), hematocrit (HCT), and platelet distribution width (PDW) were associated with MetS prevalence. Compared with the lowest tertile (Q1), the odds ratios (ORs) for Q2 and Q3 of WBC were 1.629 (95% CI: 1.164-2.279, P = 0.004) and 1.621 (95% CI: 1.14-2.292, P = 0.006), respectively. For Hb, the ORs in Q2 and Q3 were 0.523 (95% CI: 0.325-0.843, P = 0.008) and 0.435 (95% CI: 0.212-0.889, P = 0.022), respectively. The ORs for HCT in Q2 and Q3 were 1.818 (95% CI: 1.123-2.943, P = 0.015) and 2.480 (95% CI: 1.208-5.089, P = 0.013), respectively. The ORs for PDW in Q2 and Q3 were 0.562 (95% CI: 0.358-0.881, P = 0.012) and 0.614 (95% CI: 0.381-0.991, P = 0.046), respectively.
    Conclusion  WBC, Hb, HCT, and PDW in the complete blood count were associated with the prevalence of MetS, WBC and HCT were risk factors for the prevalence of MetS, while Hb and PDW were protective factors. It is recommended that complete blood counts be included in the monitoring and management of metabolic diseases.

     

/

返回文章
返回